Antibiotic treatment can be safely stopped in asymptomatic patients with prosthetic joint infections despite

R J Piso1, R Elke

  • 1Medizinische Klinik, Kantonsspital, Baslerstrasse 150, 4600 Olten, Switzerland. jpiso_ol@spital.ktso.ch

Infection
|April 9, 2010
PubMed
Abstract

Insights

Antimicrobial therapy for prosthetic joint infection can be safely discontinued even with elevated C-reactive protein (CRP) levels if clinical signs of infection are absent and CRP has plateaued. This approach ensures effective treatment while managing persistent inflammatory markers.

Area of Science:

  • Orthopedic Surgery
  • Infectious Diseases
  • Biomarkers

Background:

  • Prosthetic joint infections (PJIs) necessitate prolonged antimicrobial therapy, typically 3-6 months.
  • Normalization of C-reactive protein (CRP) is often a prerequisite for discontinuing antibiotic treatment.
  • Persistent, mild elevation of CRP can occur despite adequate PJI treatment.

Purpose of the Study:

  • To evaluate the safety and efficacy of stopping antibiotic therapy in patients with PJI when CRP levels remain elevated but stable.
  • To determine if clinical recovery and CRP plateau are sufficient criteria for treatment cessation.

Main Methods:

  • A cohort of 14 patients with PJI (hip and knee) and persistently elevated CRP (>5 mg/L) was observed.
  • Surgical interventions included débridement with prosthesis retention or staged reimplantation.
  • Antibiotic therapy was ceased based on clinical stability and a plateau in CRP levels, not normalization.
  • Patients were followed for 2 years post-diagnosis.

Main Results:

  • Only one patient experienced a subsequent infection, which was deemed a reinfection due to a different pathogen.
  • The remaining 13 patients remained infection-free throughout the 2-year follow-up period.
  • This suggests that achieving a CRP plateau is a reliable indicator for treatment cessation.

Conclusions:

  • Antibiotic treatment for PJI can be safely discontinued in clinically stable patients, even if CRP levels do not normalize.
  • A plateau in CRP values, alongside the absence of clinical infection signs, is a viable criterion for ending antimicrobial therapy.
  • This finding challenges the strict requirement for CRP normalization in PJI treatment protocols.

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...